M. I. Chernenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
M. I. Chernenko has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Anton Vladimirovich Minaev
A.N. Bakulev Center for Cardiovascular Surgery of the Russian Ministry of Health
1 shared publication - E. V. Lyubkina
Bakulev Scientific Center for Cardiovascular Surgery Russian Academy of Medical Sciences (A.N. Bakulev Center)
1 shared publication - Igor A. Kovalev
A.N. Bakulev National Medical Research Center for Cardiovascular Surgery of the Russian Ministry of Health
1 shared publication - O. I. Medvedeva
Bakulev Scientific Center for Cardiovascular Surgery Russian Academy of Medical Sciences (A.N. Bakulev Center)
1 shared publication - Sergey Pavlovich Glyantsev
FSBI «National Medical Research Center named after A.V. Vishnevsky» of the Ministry of Health of the Russian Federation; FSAEI of HE «I.M. Sechenov First Moscow State Medical University» of the Ministry of Health of the Russian Federation (Sechenov University)
1 shared publication - Timur Yur'EVich Danilov
Bakulev National Medical Research Center of Cardiovascular Surgery
1 shared publication
Latest Publications
- 9 July 2026
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 41 (2)
Life-threatening arrhythmias and sudden cardiac death in congenital heart disease with systemic right ventricle (a literature review)
Adult patients with congenital heart disease (ACHD) remain a poorly studied group in terms of arrhythmological complications, while at the same time representing one of the most actively investigated cohorts with arrhythmias today. Patients with a systemic right ventricle (sRV) after atrial switch operations or with congenitally corrected transposition of the great arteries are the most vulnerable subgroups in the congenital heart disease (CHD) population; however, specific criteria for sudden cardiac death (SCD) risk stratification in these patients are still lacking. This review summarizes current knowledge on the incidence and mechanisms of SCD, including the role of arrhythmogenic substrate, myocardial fibrosis, anatomical and physiological characteristics of the sRV, and the systemic atrioventricular valve. Data from national and international registries are presented, as well as recommendations for rhythm monitoring and detection of life-threatening arrhythmias, along with the latest risk stratification scores developed specifically for patients with sRV. The need for prolonged rhythm surveillance, refinement of indications for implantable cardioverter-defibrillators in primary prevention, and further research with registry data collection to optimize management strategies is emphasized.
- 9 July 2026
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 41 (2)
Life-threatening arrhythmias and sudden cardiac death in congenital heart disease with systemic right ventricle (a literature review)
Adult patients with congenital heart disease (ACHD) remain a poorly studied group in terms of arrhythmological complications, while at the same time representing one of the most actively investigated cohorts with arrhythmias today. Patients with a systemic right ventricle (sRV) after atrial switch operations or with congenitally corrected transposition of the great arteries are the most vulnerable subgroups in the congenital heart disease (CHD) population; however, specific criteria for sudden cardiac death (SCD) risk stratification in these patients are still lacking. This review summarizes current knowledge on the incidence and mechanisms of SCD, including the role of arrhythmogenic substrate, myocardial fibrosis, anatomical and physiological characteristics of the sRV, and the systemic atrioventricular valve. Data from national and international registries are presented, as well as recommendations for rhythm monitoring and detection of life-threatening arrhythmias, along with the latest risk stratification scores developed specifically for patients with sRV. The need for prolonged rhythm surveillance, refinement of indications for implantable cardioverter-defibrillators in primary prevention, and further research with registry data collection to optimize management strategies is emphasized.
- Open Access
- 18 September 2022
- Published by IPO Association of Transplantologists in Transplantologiya. The Russian Journal of Transplantation
- Vol. 14 (3) , 371-390
PHENOMENON OF DEMIKHOV. Heart transplantation in experiment and clinical cases in the USSR and abroad (1968–1972). The Second in the USSR heart transplantation in a Clinic (Solovyev G.M., June 10, 1971)
The article presents materials of Soviet and foreign medical literature of 1968–1972 devoted to heart transplantation in experiment and clinical practice. It is shown that in the USSR after unsuccessful heart transplantation performed by A.A. Vishnevsky on November 4, 1968, experimental studies on isolated heart preservation in order to preserve its viability were conducted; models of orthotopic and heterotopic heart transplantation on large and small animals were created; morphological, physiological, biochemical and immunological changes in the transplanted heart were studied. The second heart transplantation in this country was performed by G.M. Solovyev on June 10, 1971, but it was also unsuccessful. It’s remarkable that the 20-year experience of V.P. Demikhov in experimental heart transplantation was used only partially: a number of surgeons applied the cardiopulmonary complex isolated according to V.P. Demikhov's technique for biological heart preservation in experimental animals. At the same time after the successful heart transplantation performed by C. Barnard on December 3, 1967, the world boom of clinical transplantation began. In 1969, 101 such operations were performed. For example, D. Cooley performed them on 21 patients and on another one performed two surgeries. There were observations that patients operated on in 1968 lived 800–900 days or more. The best results were shown by R. Lower, M. DeBakey and N. Shumway. However, the vast majority of heart transplants resulted in lethal outcomes in the immediate or distant postoperative period. This led to the fact that the euphoria of successful transplants gradually began to diminish: in 1969 only 47 operations were performed, and in 1970–1971 only 17 surgeries per year.
- 18 September 2022
- Published by IPO Association of Transplantologists in Transplantologiya. The Russian Journal of Transplantation
- Vol. 14 (3) , 371-390
Open AccessPHENOMENON OF DEMIKHOV. Heart transplantation in experiment and clinical cases in the USSR and abroad (1968–1972). The Second in the USSR heart transplantation in a Clinic (Solovyev G.M., June 10, 1971)
The article presents materials of Soviet and foreign medical literature of 1968–1972 devoted to heart transplantation in experiment and clinical practice. It is shown that in the USSR after unsuccessful heart transplantation performed by A.A. Vishnevsky on November 4, 1968, experimental studies on isolated heart preservation in order to preserve its viability were conducted; models of orthotopic and heterotopic heart transplantation on large and small animals were created; morphological, physiological, biochemical and immunological changes in the transplanted heart were studied. The second heart transplantation in this country was performed by G.M. Solovyev on June 10, 1971, but it was also unsuccessful. It’s remarkable that the 20-year experience of V.P. Demikhov in experimental heart transplantation was used only partially: a number of surgeons applied the cardiopulmonary complex isolated according to V.P. Demikhov's technique for biological heart preservation in experimental animals. At the same time after the successful heart transplantation performed by C. Barnard on December 3, 1967, the world boom of clinical transplantation began. In 1969, 101 such operations were performed. For example, D. Cooley performed them on 21 patients and on another one performed two surgeries. There were observations that patients operated on in 1968 lived 800–900 days or more. The best results were shown by R. Lower, M. DeBakey and N. Shumway. However, the vast majority of heart transplants resulted in lethal outcomes in the immediate or distant postoperative period. This led to the fact that the euphoria of successful transplants gradually began to diminish: in 1969 only 47 operations were performed, and in 1970–1971 only 17 surgeries per year.